Gland Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '23
Sep '23
Jun '23
Mar '23
Dec '22
Total Qtr Revenue cr
1,582.55
1,426.58
1,246.24
823.95
999.80
Other Income Qtr Cr37.3953.1637.5438.9461.51
Operating Revenues Qtr1,545.161,373.421,208.69785.01938.29

*All values are in Cr.

Operating Expenses Qtr
1,188.77
1,049.35
914.74
616.59
648.72
Operating Profit Qtr
356.39
324.08
293.95
168.42
289.57
EBIDT Qtr Cr
393.78
377.23
331.50
150.90
351.08
Depreciation Qtr
105.34
81.30
65.32
37.54
37.61
Net Profit Qtr
191.86
194.08
194.10
78.68
231.95
Basic EPS Qtr
11.65
11.78
11.79
4.78
14.08
Open Demat Account
or Resume your Application
+91 -

personImage